
Stock Trend Analysis Report
Prepared for you on Monday, March 20, 2023.
Altamira Therapeutics Ltd. - Common Shares (NASDAQ:CYTO)
Strong Downtrend (-100) - CYTO is in a strong downtrend that is likely to continue. With short-term, intermediate, and long-term bearish momentum, CYTO continues to fall. Traders should use caution and set stops.
Is it time to buy, sell, or avoid CYTO?
MarketClub looks at technical strength and momentum to determine if the timing is right for CYTO.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
![]() |
|||||||||||||||
|
MarketClub’s Trade Triangles for CYTO
The long-term trend has been DOWN since Jun 10th, 2022 at 0.6208
The intermediate-term trend has been DOWN since Mar 6th, 2023 at 2.2601
The short-term trend has been DOWN since Mar 10th, 2023 at 1.2500
Smart Scan Analysis for CYTO
Based on our trend formula, CYTO is rated as a -100 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).

Open | High | Low | Price | Change |
---|---|---|---|---|
1.43 | 1.43 | 1.27 | 1.35 | -0.09 |
Prev. Close | Volume | Bid | Ask | Time |
1.35 | 88059 | 2023-03-17 15:59:50 |
52wk High | 43 | 52wk High Date | 2022-04-11 |
52wk Low | 1.2 | 52wk Low Date | 2023-03-10 |
Average Volume | 1,635,927 | Shares Outstanding | 571 |
Assets | 18,838,598M | Liabilities | 6,134,070M |
P/E Ratio | -1.90960000 |